Melatonin Agonist Treatment

Patent No. EP2028937 (titled "Melatonin Agonist Treatment") was filed by Vanda Pharmaceuticals on May 22, 2007. The application was issued on Jun 27, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKOct 28, 2015FRKELLY
SANDOZOct 23, 2015FACHINI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2028937

VANDA PHARMACEUTICALS
Application Number
EP07797634A
Filing Date
May 22, 2007
Status
Patent Maintained As Amended
May 25, 2018
Publication Date
Jun 27, 2018